APA

Gurrieri J., Lous M. L., Renson F. J., Tourne C., Voegelin H., Majoie B. & Wüfert E. (19761020). Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178). : Arzneimittel-Forschung.

Chicago

Gurrieri J, Lous M L, Renson F J, Tourne C, Voegelin H, Majoie B and Wüfert E. 19761020. Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178). : Arzneimittel-Forschung.

Harvard

Gurrieri J., Lous M. L., Renson F. J., Tourne C., Voegelin H., Majoie B. and Wüfert E. (19761020). Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178). : Arzneimittel-Forschung.

MLA

Gurrieri J, Lous M L, Renson F J, Tourne C, Voegelin H, Majoie B and Wüfert E. Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178). : Arzneimittel-Forschung. 19761020.